Heparanase inhibitor PI-88 as adjuvant therapy for hepatocellular carcinoma after curative resection: A randomized phase II trial for safety and optimal dosage (Q58814483)
Jump to navigation
Jump to search
scientific article published on 15 February 2009
Language | Label | Description | Also known as |
---|---|---|---|
English | Heparanase inhibitor PI-88 as adjuvant therapy for hepatocellular carcinoma after curative resection: A randomized phase II trial for safety and optimal dosage |
scientific article published on 15 February 2009 |
Statements
Heparanase inhibitor PI-88 as adjuvant therapy for hepatocellular carcinoma after curative resection: a randomized phase II trial for safety and optimal dosage (English)
Po-Huang Lee
Deng-Yn Lin
Cheng-Chung Wu
Long-Bin Jeng
Pin-Wen Lin
King-Tong Mok
Wei-Chen Lee
Hong-Zen Yeh
Sheng-Shun Yang
Ching-Chih Lee
Ming-Chin Yu
Cheng-Yuan Peng
Kuan-Lang Lai
Stanley Shi-Chung Chang
15 February 2009